Candidate 0 9 0 9 O
to 10 12 10 12 O
undergo 13 20 13 20 O
immune 21 27 21 27 B-treatment
checkpoint 28 38 28 38 I-treatment
inhibitor 39 48 39 48 I-treatment
( 49 50 49 50 I-treatment
ICI 50 53 50 53 I-treatment
) 53 54 53 54 I-treatment
therapy 55 62 55 62 I-treatment
for 63 66 63 66 O
SCLC 67 71 67 71 B-cancer
or 72 74 72 74 O
NSCLC 75 80 75 80 B-cancer
( 81 82 81 82 O
ICI 82 85 82 85 O
as 86 88 86 88 O
any 89 92 89 92 O
line 93 97 93 97 O
of 98 100 98 100 O
chemotherapy 101 113 101 113 B-treatment
is 114 116 114 116 O
acceptable 117 127 117 127 O
) 127 128 127 128 O
as 129 131 129 131 O
deemed 132 138 132 138 O
by 139 141 139 141 O
individual 142 152 142 152 O
's 152 154 152 154 O
treating 155 163 155 163 O
oncologist 164 174 164 174 O

Coagulopathy 0 12 175 187 B-chronic_disease
with 13 17 188 192 O
international 18 31 193 206 B-clinical_variable
normalized 32 42 207 217 I-clinical_variable
ratio 43 48 218 223 I-clinical_variable
( 49 50 224 225 I-clinical_variable
INR 50 53 225 228 I-clinical_variable
) 53 54 228 229 I-clinical_variable
> 55 56 230 231 O
2.0 57 60 232 235 B-lower_bound
or 61 63 236 238 O

Coagulopathy 0 12 239 251 B-treatment
with 13 17 252 256 O
platelets 18 27 257 266 B-clinical_variable
( 28 29 267 268 I-clinical_variable
Plt 29 32 268 271 I-clinical_variable
) 32 33 271 272 I-clinical_variable
< 34 35 273 274 O
10 36 38 275 277 B-upper_bound
k 39 40 278 279 I-upper_bound

Confirmed 0 9 280 289 O
diagnosis 10 19 290 299 O
of 20 22 300 302 O
non 23 26 303 306 B-cancer
- 26 27 306 307 I-cancer
small 27 32 307 312 I-cancer
cell 33 37 313 317 I-cancer
lung 38 42 318 322 I-cancer
cancer 43 49 323 329 I-cancer
( 50 51 330 331 I-cancer
NSCLC 51 56 331 336 I-cancer
) 56 57 336 337 I-cancer
or 58 60 338 340 O
small 61 66 341 346 B-cancer
cell 67 71 347 351 I-cancer
lung 72 76 352 356 I-cancer
cancer 77 83 357 363 I-cancer
( 84 85 364 365 I-cancer
SCLC 85 89 365 369 I-cancer
) 89 90 369 370 I-cancer

Enrollment 0 10 371 381 O
into 11 15 382 386 O
this 16 20 387 391 O
study 21 26 392 397 O
may 27 30 398 401 O
occur 31 36 402 407 O
in 37 39 408 410 O
tandem 40 46 411 417 O
with 47 51 418 422 O
other 52 57 423 428 B-treatment
clinical 58 66 429 437 I-treatment
therapeutics 67 79 438 450 I-treatment
trials 80 86 451 457 I-treatment
occurring 87 96 458 467 O
at 97 99 468 470 O
Vanderbilt 100 110 471 481 O
University 111 121 482 492 O
Medical 122 129 493 500 O
Center 130 136 501 507 O
( 137 138 508 509 O
VUMC 138 142 509 513 O
) 142 143 513 514 O
as 144 146 515 517 O
long 147 151 518 522 O
as 152 154 523 525 O
this 155 159 526 530 O
trial 160 165 531 536 O
does 166 170 537 541 O
not 171 174 542 545 O
violate 175 182 546 553 O
protocol 183 191 554 562 O
or 192 194 563 565 O
inclusion 195 204 566 575 O
criteria 205 213 576 584 O
of 214 216 585 587 O
that 217 221 588 592 O
study 222 227 593 598 O

Inability 0 9 599 608 O
to 10 12 609 611 O
perform 13 20 612 619 O
informed 21 29 620 628 O
consent 30 37 629 636 O
due 38 41 637 640 O
to 42 44 641 643 O
any 45 48 644 647 O
medical 49 56 648 655 B-chronic_disease
or 57 59 656 658 I-chronic_disease
psychiatric 60 71 659 670 I-chronic_disease
condition 72 81 671 680 I-chronic_disease

Prior 0 5 681 686 B-treatment
therapy 6 13 687 694 I-treatment
with 14 18 695 699 I-treatment
anti 19 23 700 704 I-treatment
- 23 24 704 705 I-treatment
PD-1 24 28 705 709 I-treatment
, 28 29 709 710 O
anti 30 34 711 715 B-treatment
- 34 35 715 716 I-treatment
PD 35 37 716 718 I-treatment
- 37 38 718 719 I-treatment
L1 38 40 719 721 I-treatment
, 40 41 721 722 O
anti 42 46 723 727 B-treatment
- 46 47 727 728 I-treatment
PD 47 49 728 730 I-treatment
- 49 50 730 731 I-treatment
L2 50 52 731 733 I-treatment
, 52 53 733 734 O
anti 54 58 735 739 B-treatment
- 58 59 739 740 I-treatment
CD137 59 64 740 745 I-treatment
, 64 65 745 746 O
or 66 68 747 749 O
anti 69 73 750 754 B-treatment
- 73 74 754 755 I-treatment
CTLA-4 74 80 755 761 I-treatment
antibody 81 89 762 770 I-treatment
( 90 91 771 772 O
including 91 100 772 781 O
ipilimumab 101 111 782 792 B-treatment
or 112 114 793 795 O
any 115 118 796 799 O
other 119 124 800 805 O
antibody 125 133 806 814 O
or 134 136 815 817 O
drug 137 141 818 822 O
specifically 142 154 823 835 O
targeting 155 164 836 845 O
T 165 166 846 847 B-cancer
- 166 167 847 848 I-cancer
cell 167 171 848 852 I-cancer
co 172 174 853 855 O
- 174 175 855 856 O
stimulation 175 186 856 867 O
or 187 189 868 870 O
checkpoint 190 200 871 881 O
pathways 201 209 882 890 O
) 209 210 890 891 O

Respiratory 0 11 892 903 B-chronic_disease
failure 12 19 904 911 I-chronic_disease
requiring 20 29 912 921 O
greater 30 37 922 929 O
than 38 42 930 934 O
6 43 44 935 936 B-lower_bound
Lpm 45 48 937 940 I-lower_bound
supplemental 49 61 941 953 B-treatment
oxygen 62 68 954 960 I-treatment
( 69 70 961 962 I-treatment
O2 70 72 962 964 I-treatment
) 72 73 964 965 I-treatment
by 74 76 966 968 O
nasal 77 82 969 974 B-treatment
cannula 83 90 975 982 I-treatment
or 91 93 983 985 O
mechanical 94 104 986 996 B-treatment
ventilation 105 116 997 1008 I-treatment
within 117 123 1009 1015 O
the 124 127 1016 1019 O
past 128 132 1020 1024 B-upper_bound
six 133 136 1025 1028 I-upper_bound
weeks 137 142 1029 1034 I-upper_bound

Subjects 0 8 1035 1043 O
with 9 13 1044 1048 O
an 14 16 1049 1051 O
active 17 23 1052 1058 O
or 24 26 1059 1061 O
recent 27 33 1062 1068 O
history 34 41 1069 1076 O
of 42 44 1077 1079 O
a 45 46 1080 1081 O
known 47 52 1082 1087 O
or 53 55 1088 1090 O
suspected 56 65 1091 1100 O
autoimmune 66 76 1101 1111 B-chronic_disease
disease 77 84 1112 1119 I-chronic_disease
or 85 87 1120 1122 O
recent 88 94 1123 1129 O
history 95 102 1130 1137 O
of 103 105 1138 1140 O
a 106 107 1141 1142 O
syndrome 108 116 1143 1151 B-chronic_disease
that 117 121 1152 1156 O
required 122 130 1157 1165 O
systemic 131 139 1166 1174 O
corticosteroids 140 155 1175 1190 O
/ 155 156 1190 1191 O
immunosuppressive 156 173 1191 1208 B-treatment
medications 174 185 1209 1220 I-treatment

